LMNA and muscular dystrophy: To develop therapeutic strategies for muscular dystrophy caused by LMNA mutations, it will be important both to identify and characterize mechanisms that regulate the proteasome-ubiquitination system and to find ways to prevent dysfunction of cell death mechanisms where abnormal protein aggregation has occurred.